Riskpilot← Back to searchSign inGet full accessSpartamed Oy
OYDissolvedY-tunnus 2602883-7Mariankatu 12-B13Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2014— employees
Revenue 2024
EUR 1,4M
-18% vs 2023
EBITDA margin
-56.5%
-499% vs 2023
Equity ratio
70.9%
Financial strength
Net profit 2024
EUR 590K
+834% vs 2023
| Revenue | EUR 1,4M | -18% |
| EBITDA | EUR -789K | -499% |
| Net profit | EUR 590K | +834% |
| Total assets | EUR 20,3M | +6% |
| Equity | EUR 14,4M | +3% |
| Employees | — | — |
Legal name
Spartamed Oy
Y-tunnus number
2602883-7
Legal form
Osakeyhtiö
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
3. helmikuuta 2014
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on kaikki laillinen liiketoiminta.
Address
Mariankatu 12-B13
Phone
+3580445278511
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 067 | 1 541 | 1 706 | 1 398 |
| Staff expenses | −1 | −2 | −49 | −49 | −50 |
| EBITDA | −1 000 | −714 | 52 | 198 | −789 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | −1 000 | −714 | 52 | 198 | −789 |
| Net financials | 224 | 1 118 | 115 | −117 | 1 540 |
| Profit before tax | −776 | 404 | 106 | −15 719 | 751 |
| Tax | −152 | 78 | 30 | −4 | 161 |
| Net profit | −624 | 327 | 75 | −80 | 590 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 19 152 | 19 224 | 19 002 | 19 162 | 20 296 |
| Equity | 13 958 | 14 134 | 14 183 | 13 953 | 14 393 |
| Long-term debt | 5 155 | 4 671 | 2 633 | 4 839 | 3 634 |
| Short-term debt | 39 | 419 | 2 186 | 370 | 2 269 |
| Total debt | 5 194 | 5 090 | 4 819 | 5 209 | 5 902 |
EBITDA margin
-56.5%
This company
15.8%
Market median
-458% vs market
20202024
Equity ratio
70.9%
This company
38.2%
Market median
+86% vs market
20202024
Return on equity
4.1%
This company
18.4%
Market median
-78% vs market
20202024
Net profit margin
42.2%
This company
8.1%
Market median
+421% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
LT | Audit | 2014 |
PJ Deputy auditor | Deputy auditor | 2022 |
SP Confidential Clerk | Confidential Clerk | 2018 |
PO Deputy Member | Deputy Member | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AO | Board of Directors | 2014 |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Spartamed Oy 
SL-Asunnot OyBoard members of Spartamed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lauri Tuomas Honkamäki | Audit | 0 companies |
| Perttu Johannes Mettomäki | Deputy auditor | 0 companies |
| Suvi Päivikki Vänskä | Confidential Clerk | 0 companies |
| Pirjo-Liisa Omar | Deputy Member | 0 companies |
| Ali Omar | Board of Directors | 0 companies |